What is Janumet XR?
Janumet XR is an extended-release combination diabetes medicine that contains two active ingredients: sitagliptin (a DPP-4 inhibitor) and metformin (an insulin-sensitizing agent). It is used to help control blood sugar in adults with type 2 diabetes.
How is Janumet XR used (and how is it different from regular Janumet)?
Because it’s “XR,” Janumet XR is designed to release the medication more slowly than an immediate-release combination product. That typically means it’s taken as an extended-release regimen (often once daily depending on the prescribed strength and titration plan). It’s commonly used when a patient’s blood sugar is not well controlled on diet/exercise alone or on one component (sitagliptin or metformin) alone.
When do people consider switching to Janumet XR?
People may be switched to Janumet XR to:
- simplify dosing with an extended-release formulation,
- improve tolerability for some patients who experience gastrointestinal side effects with immediate-release metformin,
- fit their regimen when metformin plus sitagliptin is already part of treatment.
What should patients watch for with Janumet XR?
Common counseling points for the sitagliptin + metformin combination generally include:
- Metformin-related GI side effects (such as nausea, diarrhea, or abdominal discomfort) and monitoring as doses are adjusted.
- Risk of low blood sugar is usually lower than with insulin or sulfonylureas when Janumet XR is not used with those drugs, but it can increase if combined with other glucose-lowering therapies.
- Kidney function monitoring is important with metformin-containing products.
If you tell me whether you’re looking for dosing, side effects, insurance/cost, or patent/exclusivity details, I can narrow the answer to what you need.